Give your eyes back the comfort screens took away
OptiLight is the first and only IPL light treatment FDA-cleared for the signs of dry eye disease caused by meibomian gland dysfunction — delivered in a calm, consultant-led setting in the heart of Leamington Spa.
Most dry eye isn't a tear problem. It's a gland problem.
Roughly 86% of dry eye disease is driven by meibomian gland dysfunction (MGD) — the tiny oil glands along your eyelids becoming blocked or inflamed, so your tears evaporate too fast, however many drops you use.1 OptiLight targets that root cause with precise pulses of light that calm inflammation and help the glands work properly again.
Results and the number of sessions needed vary by individual. OptiLight is intended as an adjunct to other dry eye care, such as gland expression, artificial tears and warm compresses.
Blocked meibomian glands
Thickened oil can't reach the tear film, so tears evaporate too quickly.
Ongoing inflammation
A cycle of irritation keeps glands from recovering on their own.
Screens make it worse
Reduced blink rate during screen use speeds up tear evaporation.
OptiLight's role
Targeted light pulses to the periocular skin help reduce inflammation and support gland function.2
Quick, comfortable, and fits around your day
A typical course is four sessions, roughly two to four weeks apart, each around fifteen minutes.
Protective eyewear on
You're seated comfortably and fitted with protective eye shields before anything begins.
Gentle pulses of light
OptiLight's Optimal Pulse Technology is applied to the skin below the eyes — most patients describe a warm, snapping sensation, nothing more.
Gland expression & review
Sukhi follows up with gentle meibomian gland expression and checks your tear film response as you progress through the course.
What a course of OptiLight can look like
Periocular skin and lid margin appearance from patients at Sukhi Eye Spa across a course of treatment.
Photographs used with patient consent. Individual results vary and are not guaranteed; OptiLight is a management for signs of dry eye disease and is not a cure. Shown alongside each patient's wider dry eye management plan.
Backed by FDA clearance and published research
OptiLight holds De Novo FDA authorisation specifically for improving the signs of dry eye disease due to meibomian gland dysfunction.
of dry eye disease cases are estimated to be driven by meibomian gland dysfunction — the mechanism OptiLight is designed to target.
Peer-reviewed studies have shown reductions in inflammatory tear cytokines and improved tear break-up time following IPL treatment for MGD.
One all-inclusive package. No hidden extras.
- Full dry eye assessment with Sukhi Cheema
- 4 OptiLight IPL sessions, spaced across your course
- Meibomian gland expression at each visit
- Follow-up review to check your results
- Personalised at-home dry eye plan
Take the 60-second dry eye symptom check
Six quick questions to see how OptiLight might help — no obligation.
Your symptoms suggest moderate dry eye signs
Based on your answers, a proper assessment with Sukhi would help confirm whether OptiLight is right for you.
Your journey with us
Consult & assess
A thorough dry eye assessment with Sukhi to confirm MGD and whether OptiLight is right for you.
Treatment
Four OptiLight sessions with gland expression, spaced two to four weeks apart.
Review & maintain
A follow-up review of your results, with a plan to help maintain comfort long-term.
A calm, clinical setting on Regent Street
OptiLight, explained
Your questions, answered
What is OptiLight and how is it different from other dry eye treatments?
Is OptiLight painful?
How many sessions will I need?
When will I notice a difference?
Am I suitable for OptiLight?
What does the £1,100 package include?
Where are you based?
Book your OptiLight consultation
Speak to Sukhi's team about whether OptiLight is right for you, or book your assessment directly.
- 📞 01926 893 0333
- ✉️ hello@sukhieyes.co.uk
- 📍 64D Regent Street, Leamington Spa, CV32 5EG